OpenAI has demonstrated that AI can improve real-world chemistry reactions used in drug development. According to the announcement, their system—trained as a discipline-specific model operating in automated laboratory settings—successfully optimized a challenging reaction in medicinal chemistry, suggesting AI is becoming a practical asset in the drug discovery pipeline.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton